MDXG
Price:
$6.86
Market Cap:
$1.02B
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which c...[Read more]
Industry
Biotechnology
IPO Date
2008-02-12
Stock Exchange
NASDAQ
Ticker
MDXG
According to MiMedx Group, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 24.50. This represents a change of -22.38% compared to the average of 31.56 of the last 4 quarters.
The mean historical PE Ratio of MiMedx Group, Inc. over the last ten years is 5.93. The current 24.50 PE Ratio has changed 41.19% with respect to the historical average. Over the past ten years (40 quarters), MDXG's PE Ratio was at its highest in in the March 2016 quarter at 192.65. The PE Ratio was at its lowest in in the September 2018 quarter at -907.60.
Average
5.93
Median
4.42
Minimum
-54.19
Maximum
78.38
Discovering the peaks and valleys of MiMedx Group, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 402.63%
Maximum Annual PE Ratio = 78.38
Minimum Annual Increase = -245.74%
Minimum Annual PE Ratio = -54.19
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 33.33 | 120.02% |
| 2023 | 15.15 | -245.74% |
| 2022 | -10.39 | -80.82% |
| 2021 | -54.19 | 171.67% |
| 2020 | -19.95 | -37.06% |
| 2019 | -31.69 | 402.63% |
| 2018 | -6.30 | -129.63% |
| 2017 | 21.28 | -72.85% |
| 2016 | 78.38 | 132.53% |
| 2015 | 33.71 | -82.81% |
The current PE Ratio of MiMedx Group, Inc. (MDXG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
12.70
5-year avg
-7.21
10-year avg
5.93
MiMedx Group, Inc.’s PE Ratio is less than Innoviva, Inc. (33.83), greater than Sana Biotechnology, Inc. (-4.90), greater than Dianthus Therapeutics, Inc. (-13.37), greater than Nektar Therapeutics (-9.05), greater than Atai Beckley N.V (-6.21), greater than Rapport Therapeutics, Inc. Common Stock (-111.43), greater than Taysha Gene Therapies, Inc. (-17.89), greater than Inhibrx Biosciences, Inc. (-8.72), greater than Syndax Pharmaceuticals, Inc. (-5.49), greater than CureVac N.V. (5.11),
| Company | PE Ratio | Market cap |
|---|---|---|
| 33.83 | $1.34B | |
| -4.90 | $1.38B | |
| -13.37 | $1.62B | |
| -9.05 | $1.17B | |
| -6.21 | $829.95M | |
| -111.43 | $1.05B | |
| -17.89 | $1.32B | |
| -8.72 | $1.27B | |
| -5.49 | $1.71B | |
| 5.11 | $1.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MiMedx Group, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MiMedx Group, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MiMedx Group, Inc.'s PE Ratio?
How is the PE Ratio calculated for MiMedx Group, Inc. (MDXG)?
What is the highest PE Ratio for MiMedx Group, Inc. (MDXG)?
What is the 3-year average PE Ratio for MiMedx Group, Inc. (MDXG)?
What is the 5-year average PE Ratio for MiMedx Group, Inc. (MDXG)?
How does the current PE Ratio for MiMedx Group, Inc. (MDXG) compare to its historical average?